References
- Anderson MJ, Jones SE, Fisher-Hoch SP, Lewis E, Hall SM, Bartlett CL, Cohen BJ, Mortimer PP, Pereira MS. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet. 1983;1:1378.
- Seishima M, Oyama Z, Yamamura M. Two-year follow-up study after human parvovirus B19 infection. Dermatology. 2003;206: 192–6.
- Dass R, Ramesh P, Ratho RK, Saxena AK, Singh S. Parvovirus B19-induced multisystem disease simulating systemic vasculitis in a young child. Rheumatol Int. 2005;25: 125–9.
- Meyer O, Kahn MF, Grossin M, Ribard P, Belmatoug N, Morinet F, Fournet JC. Parvovirus B19 infection can induce histiocytic nec-rotizing lymphadenitis (Kikuchi's disease) associated with sys-temic lupus erythematosus. Lupus. 1991;1: 37–41.
- Yufu Y, Matsumoto M, Miyamura T, Nishimura J, Nawata H, Ohshima K. Parvovirus B19-associated haemophagocytic syn-drome with lymphadenopathy resembling histiocytic necrotizing lymphadenitis (Kikuchi's disease). Br J Haematol. 1991; 96:868–71.
- Seishima M, Mizutani Y, Shibuya Y, Arakawa C. Chronic fatigue syndrome after human parvovirus B19 infection without persis-tent viremia. Dermatology. 2008;216:341–6.
- Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 2008;25: 1271–7.
- Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythe-matosus. Arthritis Rheum. 1997;40:1725.
- Bombardier C, Gladman DD, Urowitz MB, Carton D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35:630–40.
- Nesher G, Osborn TG, Moore TL. Parvovirus infection mim-icking systemic lupus erythematosus. Semin Arthritis Rheum. 1995;24:297–303.
- Tanaka A, Sugawara A, Sawai K, Kuwahara T. Human parvo-virus B19 infection resembling systemic lupus erythematosus. Intern Med. 1998;37:708–10.
- Chassagne PL, Mejjad O, Gourmelen O, Moore N, Le Loet X, Deshayes P. Exacerbation of systemic lupus erythematosus dur-ing human parvovirus B19 infection. Br J Rheumatol. 1993;32:158–9.
- Hsu T-C, Tsay GJ. Human parvovirus B19 infection in patients with systemic lupus erythematosus. Rheumatology. 2001; 40:152–7.
- Seishima M, Shibuya Y, Suzuki S, Arakawa C. Acute heart failure associated with human parvovirus B19 infection. Clin Exp Dermatol. 2008;33:588–90.
- Richards M, Johns J. Effusive-constrictive pericarditis associated with human parvovirus B19 infection. Scand J Infect Dis. 2005;37:609–23.
- Orth T, Herr W, Spahn T, Voigtländer T, Michel D, Mertens T, Mayet WJ, Dippold W, Meyer zum Bilschenfelde KH. Human parvovirus B19 infection associated with severe acute perimyo-carditis in a 34-year-old man. Eur Heart J. 1997;18: 524–5.
- Nigro G, Bastianon V, Colloridi V, Ventriglial F, Gallo P, D'Amati G, Koch WC, Adler SP. Human parvovirus B19 infection in infancy associated with acute and chronic lympho-cytic myocarditis and high cytokine levels: report of 3 cases and review. Clin Infect Dis. 2000;31: 65–9.
- Munro K, Croxson MC, Thomas S, Wilson NJ. Three cases of myocarditis in childhood associated with human parvovirus B19 infection (B19 virus). Pediatr Cardiol. 2003;24:472–5.
- Morris CN, Smilack JD. Parvovirus B19 infection associated with respiratory distress. Clin Infect Dis. 1998;27:900–1.
- Suzuki T, Saito S, Hirabayashi Y, Harigae H, Ishii T, Kodera T, Fujii H, Munakata Y, Sasaki T. Human parvovirus B19 infection during the inactive stage of systemic lupus erythematosus. Intern Med. 2003;42: 538–40.